Media Room

Wesana Health CEO Daniel Carcillo to Keynote Charles River Symposium: Re-Imagining Substance Abuse, Addiction, and Mental Health Disorders with Psychedelic Therapies

Wesana Health CEO Daniel Carcillo to Keynote Charles River Symposium: Re-Imagining Substance Abuse, Addiction, and Mental Health Disorders with Psychedelic…

150 150 Wesana Health

Wesana Announces First Quarter 2022 Financial Results

Wesana Announces First Quarter 2022 Financial Results May 31, 2022 17:30 ET | Source: www.wesanahealth.com. Investor Relations: Keenan Gentry Email: IR@wesanahealth.com Phone:…

150 150 Wesana Health

Wesana Health Outlines Accelerated Drug Development Pathway

Wesana Health Outlines Accelerated Drug Development Pathway May 10, 2022 07:30 ET  CHICAGO and TORONTO, May 10, 2022 (GLOBE NEWSWIRE)…

150 150 Wesana Health

WESANA HEALTH OUTLINES ACCELERATED DRUG DEVELOPMENT PATHWAY

CHICAGO and TORONTO, May 10, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven…

150 150 Wesana Health

Wesana Health CEO Daniel Carcillo to Speak at Several Leading Investor and Industry Events

CHICAGO and TORONTO, March 29, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF),…

150 150 Wesana Health

Wesana Health Announces New Findings Indicating Psilocybin Potentiates Impact of an Anti-Depressant

CHICAGO and TORONTO, March 22, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF),…

150 150 Wesana Health

Brain Injury Awareness Month: New Hope With Psychedelic Medicine

Psychedelic Stock Watch

https://psychedelicstockwatch.com/psychedelic-stock-news/brain-injury-awareness-month-new-hope-with-psychedelic-medicine
800 450 Wesana Health

Wesana Health Announces Positive Feedback From Pre-IND Meeting With FDA on SANA-013

Pre-IND Meeting is a Significant Milestone in the Clinical Development of SANA-013, Defining the Pathway to Initiate in-Human Clinical Trials…

150 150 Wesana Health

Wesana Provides Updates on Build-out of Third Clinic

Naperville clinic to open Spring 2022 CHICAGO and TORONTO, March 11, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc.  (“Wesana”…

150 150 Wesana Health

From NHL Enforcer To CEO: Daniel Carcillo’s New Company Wants To Treat Traumatic Brain Injury With Psilocybin

Forbes

https://www.forbes.com/sites/amandasiebert/2021/01/22/from-nhl-enforcer-to-ceo-daniel-carcillos-new-company-wants-to-treat-traumatic-brain-injury-with-psilocybin/?sh=6217757b1af6
150 150 Wesana Health

Wesana Health Announces Positive Findings From Animal Study on Novel Depression Treatment Protocol Combining Psilocybin and Cannabidiol

Wesana’s novel and proprietary depression treatment protocol that includes a single high dose of psilocybin followed by a maintenance regimen…

150 150 Wesana Health

Wesana Health Granted US FDA Pre-IND Meeting for SANA-013

The meeting is scheduled for March 11, 2022 CHICAGO and TORONTO, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc.  (“Wesana”…

150 150 Wesana Health
Start Typing